The aim of this study is to register the drug treatment of depression in patients with epilepsy in East China.
As the treatment rate for depression in epilepsy is unclear and the discordant voice of choosing antidepressants for most doctors, this prospective observational cohort study was designed to better understand the current situation of drug treatments in patients with the comorbidity of epilepsy and depression in East China. The secondary outcome was to investigate whether baseline depressive symptoms had an influence on seizure-control in patients with epilepsy at follow-up.
Study Type
OBSERVATIONAL
Enrollment
320
Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China
Shanghai, Shanghai Municipality, China
RECRUITINGDepartment of Neurology, Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
RECRUITINGAnhui Provincial Hospital
the drug treatment rate of depression in patients with epilepsy
the drug treatment rate at baseline and 6 months at follow-up
Time frame: 6 months
the influence of depression on seizure-control
whether depression at baseline affects seizure-control 6 months later
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hefei, China
Nanjing Brain Hospital
Nanjing, China
RECRUITINGShanghai General Hospital
Shanghai, China
RECRUITINGThe Second Affiliated Hospital of Suzhou University
Suzhou, China
RECRUITINGThe First Affiliated Hospital of Wenzhou Medical University
Wenzhou, China
RECRUITING